BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24134659)

  • 1. Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats.
    Roberts ES; Vanlare KA; Strehlau G; Peyrou M; Roycroft LM; King S
    J Vet Pharmacol Ther; 2014 Apr; 37(2):161-8. PubMed ID: 24134659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of lotilaner flavoured chewable tablets (Credelio
    Kuntz EA; Kammanadiminti S
    Parasit Vectors; 2018 Jul; 11(1):409. PubMed ID: 30001745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety following dose tapering of ciclosporin in cats with hypersensitivity dermatitis.
    Roberts ES; Tapp T; Trimmer A; Roycroft L; King S
    J Feline Med Surg; 2016 Nov; 18(11):898-905. PubMed ID: 26316515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
    Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirmatory field study for the evaluation of ciclosporin at a target dose of 7.0 mg/kg (3.2 mg/lb) in the control of feline hypersensitivity dermatitis.
    Roberts ES; Speranza C; Friberg C; Griffin C; Steffan J; Roycroft L; King S
    J Feline Med Surg; 2016 Nov; 18(11):889-897. PubMed ID: 26965676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F; Perico N; Pisoni R; Anedda MF; Signorini O; Caruso R; Gotti E; Remuzzi G
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of cyclosporine after intravenous and multi-dose oral administration in cats.
    Mehl ML; Kyles AE; Craigmill AL; Epstein S; Gregory CR
    J Vet Pharmacol Ther; 2003 Oct; 26(5):349-54. PubMed ID: 14633187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs.
    Navarro C; Séguy L; Vila M; Birckel P
    BMC Vet Res; 2016 Mar; 12():54. PubMed ID: 26970736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cyclosporine A at a high-peak concentration of twice-daily infusion and oral administration in allogeneic haematopoietic stem cell transplantation.
    Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Shibuya Y; Kato M; Takahashi M; Miura I
    J Clin Pharm Ther; 2011 Aug; 36(4):518-24. PubMed ID: 21105879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of multiple oral dosing of itraconazole on the pharmacokinetics of cyclosporine in cats.
    Katayama M; Katayama R; Kamishina H
    J Feline Med Surg; 2010 Jun; 12(6):512-4. PubMed ID: 20371199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
    Kovarik JM; Villamil F; Otero A; Levy G; Lynch S; Cillo U; Fischer L; Nashan B; Pollard S; De Carlis L
    Clin Transplant; 2008; 22(1):68-75. PubMed ID: 18217908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis.
    Dip R; Carmichael J; Letellier I; Strehlau G; Roberts E; Bensignor E; Rosenkrantz W
    BMC Vet Res; 2013 Sep; 9():173. PubMed ID: 24004561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cyclosporine with phenobarbital in cats: a preliminary study.
    Hoshino Y; Inden T; Otaka R; Fukui D; Satoh H; Katayama M
    J Vet Med Sci; 2019 Nov; 81(11):1621-1623. PubMed ID: 31597813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing and safety of cyclosporine in patients with severe brain injury.
    Hatton J; Rosbolt B; Empey P; Kryscio R; Young B
    J Neurosurg; 2008 Oct; 109(4):699-707. PubMed ID: 18826358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of clarithromycin with cyclosporine in cats: pharmacokinetic study and case report.
    Katayama M; Nishijima N; Okamura Y; Katayama R; Yamashita T; Kamishina H; Uzuka Y
    J Feline Med Surg; 2012 Apr; 14(4):257-61. PubMed ID: 22412163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of relative timing of sirolimus and cyclosporine microemulsion formulation coadministration on the pharmacokinetics of each agent.
    Kaplan B; Meier-Kriesche HU; Napoli KL; Kahan BD
    Clin Pharmacol Ther; 1998 Jan; 63(1):48-53. PubMed ID: 9465841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group.
    Barone G; Chang CT; Choc MG; Klein JB; Marsh CL; Meligeni JA; Min DI; Pescovitz MD; Pollak R; Pruett TL; Stinson JB; Thompson JS; Vasquez E; Waid T; Wombolt DG; Wong RL
    Transplantation; 1996 Mar; 61(6):875-80. PubMed ID: 8623152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats.
    Heit MC; Stallons LJ; Seewald W; Thompson CM; Toutain CE; King SB; Helbig R
    BMC Vet Res; 2020 Sep; 16(1):355. PubMed ID: 32988403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.